Here are the 10-K annual reports from United-Guardian, Inc. (UG) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow UG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UG filings page.
United-Guardian, Inc. reports 2025 net sales of $10.5M, down from $12.2M in 2024, as cosmetic ingredient revenue fell sharply, especially with its largest distributor ASI. Net income declined to $2.1M from $3.3M, with gross margin easing to 49%.
Pharmaceutical products, led by Renacidin, grew to 51% of sales and medical lubricants rose modestly, while cosmetic ingredients fell to 29%. The company generated positive operating cash flow, held $7.3M in marketable securities, carried no debt, and paid cash dividends totaling $0.60 per share in 2025.